Researchers have identified 921 chemicals thought to increase the risk of breast cancer and say none should be considered "low hazard" until further investigation is done.
Oncology
Los Angeles-based Cedars-Sinai is using artificial intelligence to improve prediction of and treatment for pancreatic cancer, according to a Jan. 22 news release.
Here are 95 oncologists and oncology leaders stepping into new roles in 2024:
In an interactive session hosted by GRAIL at Becker's 11th Annual CEO + CFO Roundtable, Roni Christopher, DHSc, senior director of care delivery at GRAIL, and Adam Whitten, vice president of operations at Mercy (St. Louis), discussed how multi-cancer early…
Biotech company Orbis Health Solutions was approved to begin a phase 3 clinical trial of its melanoma vaccine, ABC News reported Jan. 20.
Advertisement
This is the first year since the COVID-19 pandemic began that hospitals must independently decide if and how to implement masking, and cancer centers across the country are taking different approaches.
Los Angeles-based UCLA Health appointed Mediget Teshome, MD, chief of breast surgery and director of breast health.
The FDA recently approved the nation's first artificial intelligence-powered medical device that detects skin cancer.
Drugmakers have their sights set on a class of cancer drugs known as antibody drug conjugates, or ADCs, to drive growth, CNBC reported Jan. 14.
The expected increase in new cancer diagnoses this year is record-setting, even as overall cancer mortality is expected to continue its decline, the American Cancer Society said in its latest report.